Discussing MDMA

Jarryd Bartle, Nicole Lee & Paula Ross

writer

Jarryd Bartle, Nicole Lee & Paula Ross

Sessional Lecturer, RMIT University | Professor at the National Drug Research Institute (Melbourne), Curtin University | Sessional psychology lecturer, Australian Catholic University

Claim CPD for this activity

Educational Activities (EA)

0 hours

These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.

Reviewing Performance (RP)

0 hours

These are activities that require reflection on feedback about your work.

Measuring Outcomes (MO)

0 hours

These are activities that use your work data to ensure quality results.

EA
0 minutes

These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.

RP
0 minutes

These are activities that require reflection on feedback about your work.

MO
0 minutes

These are activities that use your work data to ensure quality results.

We all want to reduce drug-related harm and ensure young people don’t take unnecessary risks. But decades of research shows fear isn’t an effective way to do this.

This week, Newscorp Australia released The Ripple Effect, a series of articles and accompanying videos about party drugs, aimed at parents of young people.

Rather than drawing on the science about reducing harm, the series overstates the nation’s drug problem and the likelihood of problems from taking MDMA (ecstasy). And it’s likely to scare the wits out of parents of teens.

So, what do parents really need to know about party drugs?

Most young people don’t use drugs

Illicit drug use among teens is low and has been in decline for nearly a decade.

Although Australians overall have a relatively high rate of MDMA use compared to similar countries, only a small proportion of teenagers (around 3%) and young adults (7%) have used MDMA in the last year. Among high school students, the overwhelming majority (94%) have never tried MDMA.

Normalising the idea that drug use isn’t that common is a key prevention strategy in drug education. If young people think “everyone” is using drugs, they are more likely to want to do it too.

PASSWORD RESET

Forgot your password or password not working? Please enter your email address. You will receive an email with the link to set a new password.

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Prof Rod Baber

Prof Rod Baber

Menopausal Hormone Therapy - What Dose of Estrogen is Best?

Dr Adam Nelson

Dr Adam Nelson

Cardiovascular Benefits of GLP1s – New Evidence

Dr Kathleen McNamee, Prof Sonia Grover

Dr Kathleen McNamee, Prof Sonia Grover

Oral Contraceptive Pill in Teens

Prof Andrew Sindone

Prof Andrew Sindone

RSV and the Heart

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Share this

Share this

Jarryd Bartle, Nicole Lee & Paula Ross

writer

Jarryd Bartle, Nicole Lee & Paula Ross

Sessional Lecturer, RMIT University | Professor at the National Drug Research Institute (Melbourne), Curtin University | Sessional psychology lecturer, Australian Catholic University

Test your knowledge

Recent articles

Latest GP poll

Do you believe the current authority prescription system should be:

Modified but kept in place

0%

Eliminated entirely without replacement

0%

Maintained as is

0%

Completely replaced with an alternative system

0%

Recent podcasts

Listen to expert interviews.
Click to open in a new tab

Find your area of interest

Once you confirm you’ve read this article you can complete a Patient Case Review to earn 0.5 hours CPD in the Reviewing Performance (RP) category.

Select ‘Confirm & learn‘ when you have read this article in its entirety and you will be taken to begin your Patient Case Review.

Menopause and MHT

Multiple sclerosis vs antibody disease

Using SGLT2 to reduce cardiovascular death in T2D

Peripheral arterial disease